Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-007453
Filing Date
2024-09-30
Accepted
2024-09-30 16:22:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3370
  Complete submission text file 0001950047-24-007453.txt   5005
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Subject) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36257 | Film No.: 241339780
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 740 BROADWAY 9TH FLOOR NEW YORK NY 10003
Business Address
Meckler Jeffrey A (Reporting) CIK: 0001506916 (see all company filings)

Type: 144